Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin and Pioglitazone for Pre-Diabetes in Kidney Transplant Patients
NCT01346254Phase 2Completed
- Start
- Dec 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vildagliptin and pioglitazone in impaired glucose tolerance (IGT). Started Dec 2009; status: completed.
02
Drugs
vildagliptinpioglitazone
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT01346254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01346254.